215 related articles for article (PubMed ID: 24122662)
1. Involvement of autophagy in cervical, endometrial and ovarian cancer.
Orfanelli T; Jeong JM; Doulaveris G; Holcomb K; Witkin SS
Int J Cancer; 2014 Aug; 135(3):519-28. PubMed ID: 24122662
[TBL] [Abstract][Full Text] [Related]
2. mTOR inhibitors and their clinical application in cervical, endometrial and ovarian cancers: a critical review.
Husseinzadeh N; Husseinzadeh HD
Gynecol Oncol; 2014 May; 133(2):375-81. PubMed ID: 24556063
[TBL] [Abstract][Full Text] [Related]
3. Rational study endpoints in anti-neoplastic agent regulatory approval trials in the gynecologic malignancies.
Markman M
Womens Health (Lond); 2016 Jul; 12(4):396-9. PubMed ID: 27638892
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy for gynecologic cancers occurring during pregnancy.
Ko EM; Van Le L
Obstet Gynecol Surv; 2011 May; 66(5):291-8. PubMed ID: 21794193
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant therapy in gynecologic malignancies. Ovarian, cervical, and endometrial cancer.
Curtin JP; Shapiro F
Surg Oncol Clin N Am; 1997 Oct; 6(4):813-30. PubMed ID: 9309095
[TBL] [Abstract][Full Text] [Related]
6. The Epigenetic Landscape in the Treatment of Gynecologic Malignancies.
Eskander RN
Am Soc Clin Oncol Educ Book; 2018 May; 38():480-487. PubMed ID: 30231335
[TBL] [Abstract][Full Text] [Related]
7. Current status of chemotherapy in gynecologic cancer.
Tropé C; Kristensen G
Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-1-S15-22. PubMed ID: 9346216
[No Abstract] [Full Text] [Related]
8. Chemotherapy for gynecologic malignancies.
Vermorken JB; Hoekman K
Curr Opin Oncol; 1995 Sep; 7(5):457-65. PubMed ID: 8541392
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapy in ovarian, endometrial and cervical cancer: State of the art and future perspectives.
Ventriglia J; Paciolla I; Pisano C; Cecere SC; Di Napoli M; Tambaro R; Califano D; Losito S; Scognamiglio G; Setola SV; Arenare L; Pignata S; Della Pepa C
Cancer Treat Rev; 2017 Sep; 59():109-116. PubMed ID: 28800469
[TBL] [Abstract][Full Text] [Related]
10. Fertility-sparing surgery for malignancies in women.
Gershenson DM
J Natl Cancer Inst Monogr; 2005; (34):43-7. PubMed ID: 15784822
[TBL] [Abstract][Full Text] [Related]
11. Role of toll-like receptors in cervical, endometrial and ovarian cancers: a review.
Husseinzadeh N; Davenport SM
Gynecol Oncol; 2014 Nov; 135(2):359-63. PubMed ID: 25135000
[TBL] [Abstract][Full Text] [Related]
12. Recent updates in the clinical use of platinum compounds for the treatment of gynecologic cancers.
Muggia FM
Semin Oncol; 2004 Dec; 31(6 Suppl 14):17-24. PubMed ID: 15726530
[TBL] [Abstract][Full Text] [Related]
13. Major clinical research advances in gynecologic cancer in 2014.
Suh DH; Lee KH; Kim K; Kang S; Kim JW
J Gynecol Oncol; 2015 Apr; 26(2):156-67. PubMed ID: 25872896
[TBL] [Abstract][Full Text] [Related]
14. Developmental DNA methyltransferase inhibitors in the treatment of gynecologic cancers.
Duenas-Gonzalez A; Medina-Franco JL; Chavez-Blanco A; Dominguez-Gomez G; Fernández-de Gortari E
Expert Opin Pharmacother; 2016; 17(3):323-38. PubMed ID: 26559668
[TBL] [Abstract][Full Text] [Related]
15. Changes in short-term health-related quality of life in women undergoing gynecologic oncologic laparotomy: an associated factor analysis.
Minig L; Vélez JI; Trimble EL; Biffi R; Maggioni A; Jeffery DD
Support Care Cancer; 2013 Mar; 21(3):715-26. PubMed ID: 22930239
[TBL] [Abstract][Full Text] [Related]
16. Cost information of chemotherapy for cervical and endometrial cancer in Japan.
Kamijo Y; Ichikawa M
Jpn J Nurs Sci; 2014 Jul; 11(3):190-9. PubMed ID: 25065965
[TBL] [Abstract][Full Text] [Related]
17. Annual report of Gynecologic Oncology Committee, Japan Society of Obstetrics and Gynecology, 2013.
Aoki D
J Obstet Gynaecol Res; 2014 Feb; 40(2):338-48. PubMed ID: 24472052
[TBL] [Abstract][Full Text] [Related]
18. An investigation of relationships between hypoxia-inducible factor-1 alpha gene polymorphisms and ovarian, cervical and endometrial cancers.
Konac E; Onen HI; Metindir J; Alp E; Biri AA; Ekmekci A
Cancer Detect Prev; 2007; 31(2):102-9. PubMed ID: 17418979
[TBL] [Abstract][Full Text] [Related]
19. Claudin-4: a potential therapeutic target in chemotherapy-resistant ovarian cancer.
Yoshida H; Sumi T; Zhi X; Yasui T; Honda K; Ishiko O
Anticancer Res; 2011 Apr; 31(4):1271-7. PubMed ID: 21508375
[TBL] [Abstract][Full Text] [Related]
20. Myeloid-Derived Suppressor Cells as Therapeutic Targets in Uterine Cervical and Endometrial Cancers.
Mabuchi S; Sasano T
Cells; 2021 Apr; 10(5):. PubMed ID: 33946532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
